These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24128700)

  • 1. Incubation period for campylobacteriosis and its importance in the estimation of incidence related to travel.
    Horn BJ; Lake RJ
    Euro Surveill; 2013 Oct; 18(40):. PubMed ID: 24128700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filling gaps in notification data: a model-based approach applied to travel related campylobacteriosis cases in New Zealand.
    Amene E; Horn B; Pirie R; Lake R; Döpfer D
    BMC Infect Dis; 2016 Sep; 16(1):475. PubMed ID: 27600394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of travel-associated gastrointestinal infections in Norway, 2009-2010: are they all actually imported?
    Guzman-Herrador B; Vold L; Nygard K
    Euro Surveill; 2012 Oct; 17(41):20294. PubMed ID: 23078812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Campylobacteriosis outbreaks in the state of Hesse, Germany, 2005-2011: raw milk yet again].
    Hauri AM; Just M; McFarland S; Schweigmann A; Schlez K; Krahn J
    Dtsch Med Wochenschr; 2013 Feb; 138(8):357-61. PubMed ID: 23404322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of domestic travel on estimating regional rates of human campylobacteriosis.
    Zinszer K; Michel P; Harđardóttir H; Kristinsson KG; Sigmundsdóttir G; St-Onge L; Reiersen J; Charland K; Lowman R;
    Epidemiol Infect; 2010 Dec; 138(12):1735-43. PubMed ID: 20492744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of spatially localised outbreaks in campylobacteriosis notification data.
    Spencer SE; Marshall J; Pirie R; Campbell D; French NP
    Spat Spatiotemporal Epidemiol; 2011 Sep; 2(3):173-83. PubMed ID: 22748176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of time series models for predicting campylobacteriosis risk in New Zealand.
    Al-Sakkaf A; Jones G
    Zoonoses Public Health; 2014 May; 61(3):167-74. PubMed ID: 23551848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis on the incubation period of Campylobacteriosis.
    Awofisayo-Okuyelu A; Hall I; Adak G; Hawker JI; Abbott S; McCARTHY N
    Epidemiol Infect; 2017 Aug; 145(11):2241-2253. PubMed ID: 28669361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of pulsed-field gel electrophoresis to identify potential outbreaks of campylobacteriosis in New Zealand.
    Gilpin B; Cornelius A; Robson B; Boxall N; Ferguson A; Nicol C; Henderson T
    J Clin Microbiol; 2006 Feb; 44(2):406-12. PubMed ID: 16455892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travellers returning to Sweden as sentinels for comparative disease incidence in other European countries, campylobacter and giardia infection as examples.
    Ekdahl K; Giesecke J
    Euro Surveill; 2004 Sep; 9(9):6-9. PubMed ID: 15381837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spatial and temporal determinants of campylobacteriosis notifications in New Zealand, 2001-2007.
    Spencer SE; Marshall J; Pirie R; Campbell D; Baker MG; French NP
    Epidemiol Infect; 2012 Sep; 140(9):1663-77. PubMed ID: 22050713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campylobacteriosis in New Zealand: results of a case-control study.
    Eberhart-Phillips J; Walker N; Garrett N; Bell D; Sinclair D; Rainger W; Bates M
    J Epidemiol Community Health; 1997 Dec; 51(6):686-91. PubMed ID: 9519133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using environmental health officers' opinions to inform the source attribution of enteric disease: further analysis of the "most likely source of infection".
    Lukacsovics A; Nesbitt A; Marshall B; Asplin R; Stone J; Embree G; Hurst M; Pollari F
    BMC Public Health; 2014 Dec; 14():1258. PubMed ID: 25496465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Travel-associated Legionnaires disease in Europe in 2009.
    Joseph CA; Ricketts KD; Yadav R; Patel S;
    Euro Surveill; 2010 Oct; 15(41):19683. PubMed ID: 20961516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for laboratory-confirmed sporadic cases of cyclosporiasis--United States, 1997-2008.
    Hall RL; Jones JL; Herwaldt BL
    MMWR Surveill Summ; 2011 Apr; 60(2):1-11. PubMed ID: 21471951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based surveillance study of Campylobacter infections in Finland.
    Nakari UM; Huovinen E; Kuusi M; Siitonen A
    Epidemiol Infect; 2010 Dec; 138(12):1712-8. PubMed ID: 20307339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the major increase in notified campylobacteriosis in New Zealand real?
    Baker MG; Sneyd E; Wilson NA
    Epidemiol Infect; 2007 Jan; 135(1):163-70. PubMed ID: 16753076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacteriosis rates show age-related static bimodal and seasonality trends.
    Nelson W; Harris B
    N Z Med J; 2011 Jun; 124(1337):33-9. PubMed ID: 21946876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporiasis Surveillance - United States, 2011-2015.
    Casillas SM; Hall RL; Herwaldt BL
    MMWR Surveill Summ; 2019 Apr; 68(3):1-16. PubMed ID: 31002104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using outbreak data for source attribution of human salmonellosis and campylobacteriosis in Europe.
    Pires SM; Vigre H; Makela P; Hald T
    Foodborne Pathog Dis; 2010 Nov; 7(11):1351-61. PubMed ID: 20586609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.